Sompo Asset Management Co. Ltd. Purchases 120 Shares of CME Group Inc. (NASDAQ:CME)

Sompo Asset Management Co. Ltd. grew its position in CME Group Inc. (NASDAQ:CMEFree Report) by 7.2% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,780 shares of the financial services provider’s stock after acquiring an additional 120 shares during the quarter. Sompo Asset Management Co. Ltd.’s holdings in CME Group were worth $350,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of CME. Capital International Investors lifted its position in shares of CME Group by 24.1% during the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after buying an additional 3,069,806 shares during the period. PineStone Asset Management Inc. lifted its position in shares of CME Group by 137.6% during the 2nd quarter. PineStone Asset Management Inc. now owns 2,260,644 shares of the financial services provider’s stock worth $444,443,000 after buying an additional 1,309,097 shares during the period. Capital World Investors lifted its position in shares of CME Group by 8.7% during the 4th quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock worth $3,072,654,000 after buying an additional 1,172,575 shares during the period. M&G Plc bought a new position in shares of CME Group during the 1st quarter worth approximately $156,631,000. Finally, Assenagon Asset Management S.A. lifted its position in shares of CME Group by 577.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 645,330 shares of the financial services provider’s stock worth $126,872,000 after buying an additional 550,133 shares during the period. Institutional investors own 87.75% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on CME. Keefe, Bruyette & Woods raised their price target on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Barclays raised their price target on CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a report on Thursday, July 25th. Bank of America cut CME Group from a “neutral” rating to an “underperform” rating and dropped their price target for the company from $212.00 to $177.00 in a report on Tuesday, September 3rd. Piper Sandler reaffirmed an “overweight” rating and set a $225.00 price target on shares of CME Group in a report on Tuesday, August 20th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a report on Thursday, August 15th. Four research analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $209.73.

View Our Latest Research Report on CME

Insider Buying and Selling

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. The disclosure for this sale can be found here. 0.30% of the stock is owned by insiders.

CME Group Stock Down 0.7 %

NASDAQ CME opened at $213.16 on Friday. The stock has a fifty day moving average of $207.86 and a 200-day moving average of $207.45. The stock has a market capitalization of $76.75 billion, a P/E ratio of 24.25, a price-to-earnings-growth ratio of 8.85 and a beta of 0.55. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $223.80. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The business had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the previous year, the firm earned $2.30 earnings per share. The firm’s quarterly revenue was up 12.7% compared to the same quarter last year. On average, equities research analysts forecast that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be paid a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.16%. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.